News on immunoassay systems and applications.
Under the plan, the president will establish a national pandemic testing board to oversee implementation of a unified approach to testing.
SureScreen's test will be deployed in educational settings, as well as for the testing of National Health Service and care home staff.
Bio-Rad's PCR-based test is designed to detect SARS-CoV-2 nucleic acid, while United Biomedical's test detects antibodies against the virus.
The firm has collaborated with Novartis to help pilot the new sickle cell disease test and a treatment in Ghana.
Compared with RT-PCR testing, Abbott's BinaxNow test had a sensitivity of 64 percent for samples from symptomatic people and nearly 36 percent for asymptomatic people.
